Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives $6.25 Consensus PT from Analysts
Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Get Free Report) has earned a consensus recommendation of “Buy” from the six analysts that are currently covering the company, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month price target among brokerages that have covered the stock in the last year […]
Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Get Free Report) has earned a consensus recommendation of “Buy” from the six analysts that are currently covering the company, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month price target among brokerages that have covered the stock in the last year […]
